4.5 Article

Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD

Journal

Publisher

ASSOC RESEARCH VISION OPHTHALMOLOGY INC
DOI: 10.1167/tvst.11.2.12

Keywords

age-related macular degeneration; sex differences; RANTES

Categories

Funding

  1. National Eye Institute of the National Institutes of Health [R01EY032456]
  2. Research to Prevent Blindness
  3. NIH/NCATS Colorado CTSA Grant [UL1 TR002535]
  4. Frederic C. Hamilton Macular Degeneration Center
  5. Sue Anschutz-Rogers Eye Center Research Fund

Ask authors/readers for more resources

The study aimed to investigate whether there are sex differences in levels of the chemokine RANTES in patients with intermediate age-related macular degeneration (iAMD) and controls with no AMD. The results showed that plasma levels of RANTES were significantly lower in males compared to females within the iAMD cohort, while there was no significant difference between males and females in the control group. These findings highlight the importance of considering sex as a biological variable in AMD research.
Purpose: To determine if there are sex differences in levels of regulated upon activation, normal T cell expressed and secreted (RANTES) in patients with intermediate age-related macular degeneration (iAMD) and in controls with no AMD. Methods: Patients with iAMD and controls defined by multi-modal imaging were recruited into a Colorado AMD registry. Plasma levels of the chemokine RANTES were measured using a multiplex assay. A nonparametric (rank-based) regression model was fit to RANTES with a sex by AMD category interaction. Results: The plasma level of RANTES was significantly higher in the control group in comparison with the iAMD group. When moderated by sex, RANTES was significantly lower (P = 0.005) in males (median, 4525.6 pg/mL; interquartile range, 2589-7861 pg/mL) compared with females (median, 6686 pg/mL; interquartile range, 3485-12488 pg/mL) within the iAMD cohort. No significant difference was found in levels of RANTES between males and females in the control group. Conclusions: We found that levels of RANTES were moderated by sex in cases with iAMD with lower levels in males compared with females. The findings illustrate the importance of including sex as a biological variable in AMD research. There is a need for further studies of RANTES, stratified by sex, in the advanced phenotypes of AMD. Translational Relevance: The biomarker RANTES identified in the plasma of patients with iAMD reflects systemic alterations when stratified by sex.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available